Evidence map›Paper›PMID 26883872›Full record

ArticleJournal of proteomics2016

3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.

David M G Anderson, Raf Van de Plas, Kristie L Rose, Salisha Hill, Kevin L Schey, Anne C Solga, David H Gutmann, Richard M Caprioli

Abstract read
In one paragraph

Article in Journal of proteomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Mass Spectrometry Imaging.Analytical chemistry · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

David M G AndersonMass Spectrometry Research Center and Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, United States.
Raf Van de PlasMass Spectrometry Research Center and Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, United States; Delft Center for Systems and Control, Delft University of Technology, Delft, The Netherlands.
Kristie L RoseMass Spectrometry Research Center and Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, United States.
Salisha HillMass Spectrometry Research Center and Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, United States.
Kevin L ScheyMass Spectrometry Research Center and Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, United States.
Anne C SolgaDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, United States.
David H GutmannDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, United States.
Richard M CaprioliMass Spectrometry Research Center and Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, United States. Electronic address: r.caprioli@vanderbilt.edu.
Vanderbilt University · USWashington University in St. Louis · US

Funding

Training (pp 214-245)P41GM103391 · NIGMS · VANDERBILT UNIVERSITY · PI REYZER, MICHELLE L · 2012 to 2020
$17.7M
Spatial Analysis of Molecules in Tissue using MALDI-MSR01GM058008 · NIGMS · VANDERBILT UNIVERSITY · PI CAPRIOLI, RICHARD M · 1998 to 2015
$5.8M
Targeting Stoma-Tumor Co-Dependency for Glioma TherapyU01CA141549 · NCI · WASHINGTON UNIVERSITY · PI GUTMANN, DAVID H · 2009 to 2013
$4.8M
NCI NIH HHS U01 CA141549NIGMS NIH HHS P41 GM103391NIGMS NIH HHS R01 GM058008
6 · The paper itself

Abstract

Neurofibromatosis type 1 (NF1) is a common neurogenetic disorder, in which affected individuals develop tumors of the nervous system. Children with NF1 are particularly prone to brain tumors (gliomas) involving the optic pathway that can result in impaired vision. Since tumor formation and expansion requires a cooperative tumor microenvironment, it is important to identify the cellular and acellular components associated with glioma development and growth. In this study, we used 3-D matrix assisted laser desorption ionization imaging mass spectrometry (MALDI IMS) to measure the distributions of multiple molecular species throughout optic nerve tissue in mice with and without glioma, and to explore their spatial relationships within the 3-D volume of the optic nerve and chiasm. 3-D IMS studies often involve extensive workflows due to the high volume of sections required to generate high quality 3-D images. Herein, we present a workflow for 3-D data acquisition and volume reconstruction using mouse optic nerve tissue. The resulting 3-D IMS data yield both molecular similarities and differences between glioma-bearing and wild-type (WT) tissues, including protein distributions localizing to different anatomical subregions. BIOLOGICAL SIGNIFICANCE: The current work addresses a number of challenges in 3-D MALDI IMS, driven by the small size of the mouse optic nerve and the need to maintain consistency across multiple 2-D IMS experiments. The 3-D IMS data yield both molecular similarities and differences between glioma-bearing and wild-type (WT) tissues, including protein distributions localizing to different anatomical subregions, which could then be targeted for identification and related back to the biology observed in gliomas of the optic nerve.

Indexed as

AnimalsBrain NeoplasmsDiazepam Binding InhibitorFiducial MarkersImaging, Three-DimensionalMiceMice, Inbred C57BLMice, Mutant StrainsMolecular ImagingMyelin Basic ProteinNeurofibromatosis 1Optic ChiasmOptic Nerve GliomaOptic Nerve NeoplasmsProteomicsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationDiazepam Binding InhibitorMyelin Basic Protein3-D imagingBottom-up proteomicsImaging mass spectrometryMALDIOptic gliomaTop-down proteomics

Identifiers

PMID26883872
PMCPMC4983271
OpenAlexW2271557649

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.